SK

Sangita Kumari

Active Director Director DIN 05197393
DIN 05197393 First appointment Feb 2012 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2012
Shareholding value •••• Premium profile

About Sangita Kumari

Data last updated:

Sangita Kumari is a Director at Protek Pharmaceuticals Private Limited (since 2012). The company operates in Trading. Protek Pharmaceuticals Private Limited reported revenue of ₹6.9 Lakh (FY 2023).

DIN 05197393
Primary Designation Director
Industry Trading
First Appointment 13 Feb 2012
Oldest Company Age 14 yrs
Largest company Protek Pharmaceuticals Private Limited · ₹6.9 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Feb 20122012₹6.9 Lakh (FY 2023)Active

Board colleagues of Sangita Kumari

NameDINCompanyDesignation
Mukesh Kumar Singh03643340Protek Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Protek Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sangita Kumari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangita Kumari

Sangita Kumari currently holds 1 directorship: Protek Pharmaceuticals Private Limited (Director, since 13 Feb 2012, revenue ₹6.9 Lakh (FY 2023)).

Sangita Kumari was first appointed on 13 Feb 2012 as Director at Protek Pharmaceuticals Private Limited.

The current boards of Sangita Kumari's companies include Mukesh Kumar Singh (Protek Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available